COL David G. McLeod
 Full Bio |
THE BICALUTAMIDE EARLY PROSTATE CANCER PROGRAM: FINDINGS OF THE NORTH AMERICAN TRIAL AT MEDIAN 5.7 YEARS’ FOLLOW-UP
David G. McLeod*, Walter Reed Army Medical Center, Washington, DC; William A. See, Medical College of Wisconsin, Milwaukee, WI;
Ira Klimberg, Urology Center of Florida, Ocala, FL; Donald Gleason, Advanced Clinical Therapeutics Inc, Tucson AZ; Gerald W. Chodak, Prostate and Urology Health Center, Chicago, IL; Tom Morris,
Jon Armstrong, AstraZeneca, Macclesfield, United Kingdom |
Abstract |
 |
PROSTATE-SPECIFIC ANTIGEN LEVELS AS A PREDICTOR OF POSITIVE BONE SCANS DURING FOLLOW-UP AFTER STANDARD CARE FOR PROSTATE CANCER: DATA FROM THE BICALUTAMIDE EARLY PROSTATE CANCER PROGRAM
Gerald W. Chodak*, Prostate and Urology Health Center, Chicago, IL; Peter Iverson, Department Of Urology, Copenhagen, Denmark; David G. McLeod, Walter Reed Army Medical Center, Washington, DC; William A. See, Medical College of Wisconsin, Milwaukee, WI; Manfred P. Wirth, Technical University of Dresden, Dresden Germany; Clive Morris, Jon Armstrong, AstraZeneca, Macclesfield, United Kingdom |
Abstract |
|
A MULTI-CENTER STUDY: SAFETY EFFICACY AND PATIENT SATISFACTION RESULTS OF THE TWO-PIECE AMBICOR INFLATABLE PENILE PROSTHESIS (IPP)
Laurence A. Levine*, Chicago, IL; Keith O’Reilly, Tacoma, WA; Ronald F. Tutrone, Baltimore, MD; David G. McLeod, Washington, DC; Ronald W. Lewis, Augusta, GA; Gerald H. Jordan, Chesapeake, VA; Marc Siegelbaum, Towson, MD; Claire C. Yang, Seattle, WA; Charles M. Feinstein, Northbrook, IL; J. Francois Eid, New York, NY; Wayne J. G. Hellstrom, New Orleans, LA; George T. Ho, Columbus, OH; Abraham Morgentaler, Brookline, MA; Arnold Melman, Bronx, NY; Robert Hackler, Richmond, VA; Stewart W. McCallum, Stanford, CA |
Abstract |
|
Shiv Srivastava
Full Bio |
EXPRESSION ANALYSIS OF NDRG1, AN ANDROGEN-INDUCED, STRESS RESPONSIVE GENE, IN PROSTATE CANCER
Toru Yoshida*, Takehiko Segawa, Takahiro Inoue, Yosuke Shimizu, Toshiyuki Kamoto, Kyoto, Japan; Taizo Shiraishi, Tsu, Japan; Shiv Srivastava, Judd Moul, Rockville, MD; Osamu Ogawa, Kyoto, Japan |
Abstract |
|
Albert Dobi
Full Bio |
THE REGULATION OF ANDROGEN RECEPTOR
LEVELS BY A FEEDBACK LOOP IN PROSTATE CANCER CELLS
Albert Dobi, Linda Xu, Vasantha
Srikantan, Shiv Srivastava |
Abstract |
|
Lionel Bañez
Full Bio |
EVALUATION OF SERUM PROTEOMIC
SELDI-TOF SPECTRAL DATA AND TUMOR VOLUME IN PATIENT WITH PROSTATE
ADENOCARCINOMA
Bañez, LL, Furusato, B, Prasanna, P, Chen,
Y, Ali, A, Moul, JW, McLeod, DG, Sesterhenn, IA and Srivastava,
S |
Abstract |
|
Syed Shaheduzzaman
Full Bio |
GENE EXPRESSION / BIOCHEMICAL PATHWAY SIGNATURES OF PROSTATE CANCER CELLS OF PATIENTS WITH HIGH RISK AND MODERATE RISK PROGRESSION OF DISEASE
Syed Shaheduzzaman, Bungo Furusato, Vasantha Srikantan,
Gyorgy Petrovics, Chunling Gao, Martin E. Nau, Michael Valladares,
Wei Zhang, Isabell A. Sesterhenn, Maryanne Vahey,
David G. McLeod, Judd W Moul and Shiv Srivastava |
Abstract |
|
| Katsuaki Masuda |
IN SILICO APPROACH FOR
THE IDENTIFICATION OF ANDROGEN RESPONSIVE ELEMENTS WITHIN
THE UPSTREAM REGULATORY SEQUENCES OF ANDROGEN-INDUCED
GENES IN PROSTATE CANCER CELLS
Masuda, K, Maheshwari, S, Oh, S, Werner,T, Srivastava, S, Dobi, A |
Abstract |
|
Vasantha Srikantan
Full Bio |
FREQUENT OVEREXPRESSION OF ETS-RELATED
GENE (ERG) IN PROSTATE CANCER TRANSCRIPTOME
REVEALSITS DIAGNOSTIC AND PROGNOSTIC POTENTIAL
Vasantha Srikantan, Gyorgy Petrovics,
Aijun Liu,
Syed Shaheduzzaman, Bungo Furasato, Chen Sun, Yongmei
Chen, Martin Nau, Lakshmi Ravindranath, Yidong Chen,
Albert Dobi,
Isabell A Sesterhenn, David G McLeod, Maryanne Vahey,
Judd W Moul, Shiv Srivastava |
Abstract |
|
MAJ Inger Rosner
|
CORRELATION OF ONE CORE POSITIVE BIOPSY FOR CANCER WITH INDEX OR TOTAL TUMOR VOLUME LESS THAN 0.5CC IN PROSTATECTOMY SPECIMENS
Inger L. Rosner*, Bungo Furusato, Timothy J. Dickason,
Charles J. Dais, Judd W. Moul, Isabell A. Sesterhenn, David G. McLeod |
|
> Meeting
Abstracts > AUA